Photo of smiling woman

Public Reporting

ACO Name and Location:

St. Rose Quality Care Network, LLC
3001 St. Rose Parkway
Henderson, NV 89052

 

ACO Primary Contact:

Primary Contact Name Margie Roper
Primary Contact Phone Number (702) 616-5719
Primary Contact Email Address Margie.Roper@DignityHealth.org

Organizational Information:

ACO Participants

ACO Participants ACO Participant in Joint Venture
Ensign Family Medicine Llc N
Scott Selco, Professional Corporation N
Dara J. Welborn, M.D., P.C. N
S and S Kim Group, PC N
Brian E. Lee, M.D., LTD N
Sports Medicine Rehabilitation Associates N
Dignity Health Medical Group Nevada, LLC N
Armour, Christensen, Simon, Chtd N
Siena Hills Primary Care, Llc N
Kochy M. Y. Tang, D.O., A Professional Corporation N
Rita B. Chuang MD LLC N

ACO Governing Body:

Member
Last Name First Name Title / Position Member’s Voting Power Membership Type ACO Participant TIN
Legal Business
Name/DBA, if
Applicable
Simon Irwin Chair 1 ACO Participant Representative Armour, Christensen, Simon, Chartered
Welborn Dara Payer Committee Chair 1 ACO Participant Representative Dara J. Welborn, M.D., P.C.
Selco Scott Finance Committee Chair 1 ACO Participant Representative Scott Selco, Professional Corporation
Flaviano Casiano 1 ACO Participant Representative Sports Medicine Rehabilitation Associates, A Flaviano Professional Corporation
Harouni Rama 1 ACO Participant Representative Dignity Health Medical Group Nevada, LLC
Pretzlaff Robert Hospital Representative: Chief Physician Executive 1 Community Stakeholder Representative N/A
Bower Joel 1 Medicare Beneficiary Representative N/A
Bertoli Troy 1 ACO Participant Representative Dignity Health Medical Group Nevada, LLC
Venkat Raji 1 ACO Participant Representative Dignity Health Medical Group Nevada, LLC
Lee Brian 1 ACO Participant Representative Brian E. Lee, M.D., LTD
Salcedo Anna Secretary 1 ACO Participant Representative Dara J. Welborn, M.D., P.C.
Ammar Tarek 1 Community Stakeholder Representative N/A

Key ACO Clinical and Administrative Leadership:

Margie Roper ACO Executive
Teresa Hong Medical Director
Dawnese Kindelt Compliance Official
Robert Pretzlaff Quality Assurance/Improvement Officer

Associated Committees and Committee leadership:

Committee Name Committee Leader Name and Position
Payer Committee Dr. Dara Welborn, Chair
Finance Committee Dr. Scott Selco, Chair
Quality Committee Vacant, Chair
Performance Evaluation Committee Dr. Anna Salcedo, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Network of individual practices of ACO professionals
  • Partnership or joint venture arrangement between hospitals and ACO professionals

Shared Savings and Losses:

Amount of Shared Savings/Losses

  • N/A

Shared Savings Distribution

  • N/A

Quality Performance Results:

2016 Quality Performance Results

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 80.51
ACO-2 CAHPS: How Well Your Providers Communicate N/A 93.01
ACO-3 CAHPS: Patients’ Rating of Provider N/A 92.25
ACO-4 CAHPS: Access to Specialists N/A 83.49
ACO-5 CAHPS: Health Promotion and Education N/A 60.32
ACO-6 CAHPS: Shared Decision Making N/A 75.40
ACO-7 CAHPS: Health Status/Functional Status N/A 72.30
ACO-34 CAHPS: Stewardship of Patient Resources N/A 26.97
ACO-8 Risk-Standardized, All Condition Readmission N/A 14.70
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented N/A 76.79
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Payment Rule Waivers:

  • No, our ACO does not use the SNF 3-Day Rule Waiver.